Erbud SA (ERB)
Warsaw Stock Exchange · Poland · prices in PLN · close of 23 Oct 2026
Key indicators
| Last close | PLN 23.00 |
|---|---|
| 52-week range | 17.80 – 35.55 |
| Return, 1 month / 3 months | +25.7% / +2.7% |
| Return, 1 year / 3 years | −22.8% / −39.9% |
| Trend | Below its 200-day average |
| RSI (14) | 53 |
| Volatility (1 year) | 34.7% |
| Worst drawdown (1 year) | -48.1% |
| Average daily value traded | 0.56M PLN |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Erbud SA is a Polish construction company based in Warsaw that carries out building and engineering projects for public and private clients. Its work covers residential housing, commercial and office buildings, industrial facilities, and infrastructure such as roads and energy installations. The group also provides general contracting and design services, and it operates through subsidiaries in Poland and in other European markets, including Germany, where it undertakes construction contracts for local and international customers.
On this site Erbud SA appears as a stock on the Warsaw Stock Exchange (Poland), code ERB, with prices in Polish zloty (PLN). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Erbud SA (ERB) trades on the Warsaw Stock Exchange in Poland. It last closed at PLN 23.00 on 23 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 373 of 580 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 22.8% and over the last three months it rose 2.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Warsaw Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 23 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -11.4% | ||
| From 52-week high | -33.9% | ||
| Momentum | 33 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 2.7% | ||
| 6-month return | -17.3% | ||
| 12-month return, skipping the last month | -38.6% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 34.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -48.1% | ||
| Liquidity | 82 · Strong | Trades actively. | |
| Average daily value traded | 0.56M PLN | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 3 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −6.3% |
|---|---|
| 1 month | +25.7% |
| 3 months | +2.7% |
| 6 months | −17.3% |
| 1 year | −22.8% |
| 3 years | −39.9% |
| 5 years | −65.5% |
Signals
| 50-day / 200-day average | 21.91 / 25.96 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.98 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 2 Jun 2025 | PLN 1.6800 |
| 21 May 2024 | PLN 1.6800 |
| 25 May 2023 | PLN 0.8400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Warsaw Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.